Joseph Breese - Sabin Vaccine Institute

More documents

Recommendations

Info

Influenza vaccines: types Intradermal Inactivated vaccines • Sanofi Pasteur • Injected Intradermally using special syringe and needle • Lower antigen content per dose (9 µg per virus strain) • Lower volume (0.1cc) • Licensed in US for 18-64 y-o • Potential advantages • Acceptability among needlephobic persons • Antigen-sparing Fluzone Intradermal Microinjection Syringe
Influenza vaccines: types High-dose Inactivated vaccine • Sanofi Pasteur • Intramuscular Injection • 0.5 cc per dose • Contains 60µg of each antigen per 0.5cc dose • Licensed in US for >65 year-olds • Advantages: better immune response may mean improved effectiveness in persons who respond poorly to standard dose vaccines (e.g. elderly) • More injection-site reactions – mostly mild
Page 1 and 2: Overview of seasonal Influenza Vacc
Page 3 and 4: Seasonal Influenza Vaccines INFLUEN
Page 5 and 6: Clinical trials of inactivated vacc
Page 7 and 8: Influenza Vaccines - overview • T
Page 9: Influenza vaccines: types “Standa
Page 13 and 14: Seasonal Influenza Vaccines VACCINE
Page 15 and 16: Influenza Vaccine efficacy if IIV i
Page 17 and 18: Vaccine effectiveness: special popu
Page 19 and 20: Indirect effects of influenza vacci
Page 21 and 22: Estimates number of medically-atten
Page 23 and 24: Influenza vaccines have been part o
Page 25 and 26: Seasonal Influenza Vaccines CHALLEN
Page 27 and 28: Gaps • Most partners need educati
Page 29: THANK YOU

Joseph Breese - Sabin Vaccine Institute

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?